Glenmede Disciplined US Value Eq Ptf holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Glenmede Disciplined U.S. Value Equity Portfolio GQLVX
- NAV / 1-Day Return 14.78 / −0.14 %
- Total Assets 2.6M
-
Adj. Expense Ratio
0.850%
- Expense Ratio 0.850%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Mid-Cap Value
- Investment Style Mid Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 1.35%
- Turnover 86%
USD | NAV as of Jul 16, 2026 | 1-Day Return as of Jul 16, 2026, 12:11 AM GMT+0
Morningstar’s Analysis GQLVX
Will GQLVX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
TechnipFMC PLC | 2.97 | 72,033 | Energy |
Bristol-Myers Squibb Co | 2.59 | 62,833 | Healthcare |
CME Group Inc Class A | 2.48 | 60,251 | Financial Services |
Johnson Controls International PLC Registered Shares | 2.29 | 55,654 | Industrials |
Omnicom Group Inc | 2.24 | 54,524 | Communication Services |
U.S. Bancorp | 2.24 | 54,506 | Financial Services |
Exelon Corp | 2.22 | 53,971 | Utilities |
APA Corp | 2.17 | 52,626 | Energy |
Hewlett Packard Enterprise Co | 2.16 | 52,549 | Technology |
Regeneron Pharmaceuticals Inc | 2.16 | 52,540 | Healthcare |